Free Trial

Billiontoone, Inc. (BLLN) - What Are Analysts Saying About This Stock?

Billiontoone logo with Healthcare background
Image from MarketBeat Media, LLC.

Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $124.38.

BLLN has been the subject of several recent research reports. Piper Sandler decreased their price objective on Billiontoone from $140.00 to $130.00 and set an "overweight" rating for the company in a report on Tuesday, November 10th. Weiss Ratings raised shares of Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research note on Monday, November 9th. Zacks Research upgraded shares of Billiontoone from a "strong sell" rating to a "hold" rating in a report on Friday, October 2nd. BTIG Research reiterated a "buy" rating and set a $130.00 target price on shares of Billiontoone in a report on Thursday, November 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of Billiontoone from $130.00 to $135.00 and gave the company an "overweight" rating in a research report on Thursday, November 5th.

View Our Latest Analysis on BLLN

Insider Transactions at Billiontoone

In other news, CTO David Tsao sold 20,000 shares of the company's stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total value of $2,184,800.00. Following the completion of the sale, the chief technology officer owned 1,000 shares of the company's stock, valued at approximately $109,240. This represents a 95.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 2,834 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $113.17, for a total transaction of $320,723.78. Following the transaction, the senior vice president owned 16,551 shares in the company, valued at approximately $1,873,076.67. This represents a 14.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 252,777 shares of company stock valued at $26,737,151. Company insiders own 50.22% of the company's stock.

Institutional Investors Weigh In On Billiontoone

Institutional investors have recently bought and sold shares of the company. Sei Investments Co. purchased a new stake in shares of Billiontoone in the first quarter worth about $1,058,000. The Manufacturers Life Insurance Company raised its position in Billiontoone by 151.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company's stock valued at $2,408,000 after acquiring an additional 18,389 shares in the last quarter. Wasatch Advisors LP raised its position in Billiontoone by 40.2% during the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company's stock valued at $62,160,000 after acquiring an additional 148,446 shares in the last quarter. Bank of America Corp DE lifted its holdings in Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company's stock valued at $1,003,000 after acquiring an additional 12,561 shares during the period. Finally, Perceptive Advisors LLC lifted its holdings in Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company's stock valued at $7,248,000 after acquiring an additional 19,000 shares during the period.

Billiontoone Price Performance

Shares of BLLN stock opened at $105.15 on Monday. Billiontoone has a twelve month low of $61.96 and a twelve month high of $150.44. The stock has a market capitalization of $5.02 billion and a price-to-earnings ratio of 114.29. The stock has a fifty day simple moving average of $106.99 and a two-hundred day simple moving average of $97.74. The company has a current ratio of 11.25, a quick ratio of 10.89 and a debt-to-equity ratio of 0.16.

About Billiontoone

(Get Free Report)

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company's molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient's blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

Further Reading

Analyst Recommendations for Billiontoone (NASDAQ:BLLN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Billiontoone Right Now?

Before you consider Billiontoone, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Billiontoone wasn't on the list.

While Billiontoone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines